These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25601323)

  • 81. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
    Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA;
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
    Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
    J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S; Rozenblit M; Lebwohl M
    J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
    Menter A; Korman NJ; Elmets CA; Feldman SR; Gelfand JM; Gordon KB; Gottlieb AB; Koo JY; Lebwohl M; Lim HW; Van Voorhees AS; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2009 Sep; 61(3):451-85. PubMed ID: 19493586
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Methotrexate in severe childhood psoriasis.
    Dogra S; Handa S; Kanwar AJ
    Pediatr Dermatol; 2004; 21(3):283-4. PubMed ID: 15165222
    [No Abstract]   [Full Text] [Related]  

  • 88. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
    Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
    J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacogenomics and the resulting impact on psoriasis therapies.
    Foulkes AC; Warren RB
    Dermatol Clin; 2015 Jan; 33(1):149-60. PubMed ID: 25412789
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Methotrexate Management in Psoriasis: Are We Following the Guidelines?
    Lindqvist T; Salah LA; Gillstedt M; Wennberg AM; Osmancevic A
    Acta Derm Venereol; 2018 Apr; 98(4):449-451. PubMed ID: 29199349
    [No Abstract]   [Full Text] [Related]  

  • 91. The pharmacological management of patients with comorbid psoriasis and obesity.
    Chiricozzi A; Gisondi P; Girolomoni G
    Expert Opin Pharmacother; 2019 May; 20(7):863-872. PubMed ID: 30794469
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris].
    Mrowietz U; Rostami-Yazdi M; Neureither M; Reich K
    J Dtsch Dermatol Ges; 2009 Apr; 7 Suppl 2():S3-16. PubMed ID: 19522921
    [No Abstract]   [Full Text] [Related]  

  • 93. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S; Mahajan R
    Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis.
    Kress DW
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S126-8. PubMed ID: 16488325
    [No Abstract]   [Full Text] [Related]  

  • 95. Cyclosporin A treatment in severe childhood psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
    Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
    J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Systemic Treatments in Pediatric Psoriasis: A Retrospective Single-Center Study.
    Sahin G; Aydin F; Pancar Yuksel E
    Arch Iran Med; 2021 Dec; 24(12):903-909. PubMed ID: 35014238
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Application of fumaric acid derivatives in psoriasis].
    van Joost T
    Ned Tijdschr Geneeskd; 1990 Dec; 134(49):2371-3. PubMed ID: 2263259
    [No Abstract]   [Full Text] [Related]  

  • 100. Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study.
    Di Lernia V; Ficarelli E; Lallas A; Possemato N; Chiarolanza I; Salvarani C
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2262-3. PubMed ID: 24911670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.